Imaging Techniques to Determine Degree of Sarcopenia and Systemic Inflammation in Advanced Renal Cell Carcinoma

Overview

Journal Curr Urol Rep

Publisher Current Science

Specialty Urology

Date 2023 Apr 10

PMID 37036632

Authors

Benjamin N Schmeusser

Adil A Ali

Florian J Fintelmann

Jose M Garcia

Grant R Williams

Viraj A Master

Sarah P Psutka

Affiliations

Soon will be listed here.

Abstract

Purpose Of Review: The purpose of this review is to provide an up-to-date understanding regarding the literature on sarcopenia and inflammation as prognostic factors in the context of renal cell carcinoma (RCC).

Recent Findings: Sarcopenia is increasingly recognized as a prognostic factor in RCC. Emerging literature suggests monitoring quantity of muscle on successive imaging and examining muscle density may be additionally informative. Inflammation has prognostic ability in RCC and is also considered a key contributor to development and progression of both RCC and sarcopenia. Recent studies suggest these two prognostic factors together may provide additional prognostic ability when used in combination. Ongoing developments include quality control regarding sarcopenia research and imaging, improving understanding of muscle loss mechanisms, and enhancing clinical incorporation of sarcopenia via improving imaging analysis practicality (i.e., artificial intelligence) and feasible biomarkers. Sarcopenia and systemic inflammation are complementary prognostic factors for adverse outcomes in patients with RCC. Further study on high-quality sarcopenia assessment standardization and expedited sarcopenia assessment is desired for eventual routine clinical incorporation of these prognostic factors.

Citing Articles

Bone mineral density as a prognostic marker in patients with biliary tract cancer undergoing surgery.

Heinrichs L, Fluegen G, Loosen S, Loberg C, Wittig L, Quaas A BJC Rep. 2024; 2(1):72.

PMID: 39323978 PMC: 11420066. DOI: 10.1038/s44276-024-00094-2.

Predictive role of preoperative sarcopenia for long-term survival in rectal cancer patients: A meta-analysis.

Su Q, Shen J PLoS One. 2024; 19(5):e0303494.

PMID: 38771764 PMC: 11108127. DOI: 10.1371/journal.pone.0303494.

Creatinine to Cystatin-C Ratio in Renal Cell Carcinoma: A Clinically Pragmatic Prognostic Factor and Sarcopenia Biomarker.

Schmeusser B, Biermann H, Nicaise E, Ali A, Patil D, Midenberg E Oncologist. 2023; 28(12):e1219-e1229.

PMID: 37540787 PMC: 10712910. DOI: 10.1093/oncolo/oyad218.

References

Stringer H, Wilson D . The Role of Ultrasound as a Diagnostic Tool for Sarcopenia. J Frailty Aging. 2018; 7(4):258-261. PMC: 6208738. DOI: 10.14283/jfa.2018.24. View

Lee K, Shin Y, Huh J, Sung Y, Lee I, Yoon K . Recent Issues on Body Composition Imaging for Sarcopenia Evaluation. Korean J Radiol. 2019; 20(2):205-217. PMC: 6342757. DOI: 10.3348/kjr.2018.0479. View

Valero 3rd V, Amini N, Spolverato G, Weiss M, Hirose K, Dagher N . Sarcopenia adversely impacts postoperative complications following resection or transplantation in patients with primary liver tumors. J Gastrointest Surg. 2014; 19(2):272-81. PMC: 4332815. DOI: 10.1007/s11605-014-2680-4. View

Blake G, Naeem M, Boutros M . Comparison of effective dose to children and adults from dual X-ray absorptiometry examinations. Bone. 2005; 38(6):935-42. DOI: 10.1016/j.bone.2005.11.007. View

Kwak J, Hwang H, Kim S, Choi J, Lee S, Bang H . Prediction of sarcopenia using a combination of multiple serum biomarkers. Sci Rep. 2018; 8(1):8574. PMC: 5988732. DOI: 10.1038/s41598-018-26617-9. View

Aslan V, Karabork Kilic A, Sutcuoglu O, Eraslan E, Bayrak A, Oksuzoglu B . Cachexia index in predicting outcomes among patients receiving immune checkpoint inhibitor treatment for metastatic renal cell carcinoma. Urol Oncol. 2022; 40(11):494.e1-494.e10. DOI: 10.1016/j.urolonc.2022.07.018. View

Aleixo G, Shachar S, Nyrop K, Muss H, Malpica L, Williams G . Myosteatosis and prognosis in cancer: Systematic review and meta-analysis. Crit Rev Oncol Hematol. 2019; 145:102839. DOI: 10.1016/j.critrevonc.2019.102839. View

Li C, Yu K, Shyh-Chang N, Jiang Z, Liu T, Ma S . Pathogenesis of sarcopenia and the relationship with fat mass: descriptive review. J Cachexia Sarcopenia Muscle. 2022; 13(2):781-794. PMC: 8977978. DOI: 10.1002/jcsm.12901. View

Steffl M, Bohannon R, Sontakova L, Tufano J, Shiells K, Holmerova I . Relationship between sarcopenia and physical activity in older people: a systematic review and meta-analysis. Clin Interv Aging. 2017; 12:835-845. PMC: 5441519. DOI: 10.2147/CIA.S132940. View

10.

Patil D, Le T, Bens K, Alemozaffar M, Lay A, Pattaras J . Dynamic Evaluation of the Modified Glasgow Prognostic Scale in Patients With Resected, Localized Clear Cell Renal Cell Carcinoma. Urology. 2020; 141:101-107. DOI: 10.1016/j.urology.2020.03.024. View

11.

Albano D, Messina C, Vitale J, Sconfienza L . Imaging of sarcopenia: old evidence and new insights. Eur Radiol. 2019; 30(4):2199-2208. DOI: 10.1007/s00330-019-06573-2. View

12.

Prado C, von Haehling S . D -Creatine dilution for body composition assessment: A direct take on the matter. J Cachexia Sarcopenia Muscle. 2022; 13(6):2593-2594. PMC: 9745462. DOI: 10.1002/jcsm.13088. View

13.

Zhang T, Ding C, Xie T, Yang J, Dai X, Lv T . Skeletal muscle depletion correlates with disease activity in ulcerative colitis and is reversed after colectomy. Clin Nutr. 2016; 36(6):1586-1592. DOI: 10.1016/j.clnu.2016.10.004. View

14.

Cushen S, Power D, Teo M, MacEneaney P, Maher M, McDermott R . Body Composition by Computed Tomography as a Predictor of Toxicity in Patients With Renal Cell Carcinoma Treated With Sunitinib. Am J Clin Oncol. 2014; 40(1):47-52. DOI: 10.1097/COC.0000000000000061. View

15.

de Jong C, Chargi N, Herder G, van Haarlem S, van der Meer F, van Lindert A . The association between skeletal muscle measures and chemotherapy-induced toxicity in non-small cell lung cancer patients. J Cachexia Sarcopenia Muscle. 2022; 13(3):1554-1564. PMC: 9178405. DOI: 10.1002/jcsm.12967. View

16.

Psutka S, Boorjian S, Moynagh M, Schmit G, Costello B, Thompson R . Decreased Skeletal Muscle Mass is Associated with an Increased Risk of Mortality after Radical Nephrectomy for Localized Renal Cell Cancer. J Urol. 2015; 195(2):270-6. DOI: 10.1016/j.juro.2015.08.072. View

17.

Komai Y, Saito K, Sakai K, Morimoto S . Increased preoperative serum C-reactive protein level predicts a poor prognosis in patients with localized renal cell carcinoma. BJU Int. 2006; 99(1):77-80. DOI: 10.1111/j.1464-410X.2006.06497.x. View

18.

Weinberg M, Shachar S, Muss H, Deal A, Popuri K, Yu H . Beyond sarcopenia: Characterization and integration of skeletal muscle quantity and radiodensity in a curable breast cancer population. Breast J. 2017; 24(3):278-284. PMC: 6414810. DOI: 10.1111/tbj.12952. View

19.

Higgins M, Martini D, Patil D, Nabavizadeh R, Steele S, Williams M . Sarcopenia and modified Glasgow Prognostic Score predict postsurgical outcomes in localized renal cell carcinoma. Cancer. 2021; 127(12):1974-1983. DOI: 10.1002/cncr.33462. View

20.

Elkassem A, Lo S, Gunn A, Shuch B, Dewitt-Foy M, Abouassaly R . Role of Imaging in Renal Cell Carcinoma: A Multidisciplinary Perspective. Radiographics. 2021; 41(5):1387-1407. DOI: 10.1148/rg.2021200202. View